Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2002 Mar;23(3):317-21.
doi: 10.1016/s0248-8663(01)00557-4.

[Tracheobronchial amyloidosis: apropos of 2 cases]

[Article in French]
Affiliations
Case Reports

[Tracheobronchial amyloidosis: apropos of 2 cases]

[Article in French]
C Cazalets et al. Rev Med Interne. 2002 Mar.

Abstract

Introduction: Tracheo-bronchial amyloidosis is an uncommon localized form of amyloidosis. We report two new cases.

Exegesis: Two patients had developed expiratory dyspnea for several months. CT-scan and flexible bronchoscopy confirmed tracheal narrowing and a diagnosis of tracheo-bronchial amyloidosis was made by tissue biopsies. The immunohistochemical type was AL in one case, undetermined in the other case. There was no argument for systemic involvement. The two patients benefited from bronchoscopic dilatation. This treatment improved clinical symptoms and pulmonary function tests with a follow up of 12 and 18 months respectively.

Conclusion: Tracheo-bronchial amyloidosis is a localised form of amyloidosis with various respiratory symptoms. Diagnosis is made by CT-scan and flexible bronchoscopy that allows biopsies. Immunohistochemical type is more often AL. Recurrence, respiratory insufficiency and tracheo-bronchial metaplasia are the most important complications. Treatment consists of bronchoscopic dilatation or excision, and bronchoscopic laser-YAG. Pulmonary function testing allows precise follow-up.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources